EPIGRAL LIMITED (EPIGRAL) financials

EPIGRAL LIMITED (EPIGRAL) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.[1]

Market Cap: ₹4,280Cr.
Current Price: ₹992
Stock P/E: 15.7
ROE: 15.8%
ROCE: 15.3%
Book Value: ₹515
Dividend Yield: 0.51%
52W High / Low: ₹1,730/806

In Jun 2026, EPIGRAL LIMITED (EPIGRAL) reported sales ₹705 Cr and net profit ₹99 Cr.

Annual TTM: sales ₹2,626 Cr, net profit ₹272 Cr.

Shareholding: Promoters 68.83% (Sep 2026), FIIs 0.99% (Sep 2026), DIIs 4.89% (Sep 2026), Government 0.02% (Sep 2026), Public 25.27% (Sep 2026).

EPIGRAL quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	626	645	628	607	587	597	736	705
Expenses	448	463	454	443	455	494	568	526
Operating Profit	178	183	173	163	132	103	169	179
OPM %	28%	28%	28%	27%	23%	17%	23%	25%
Other Income	6	4	3	8	2	6	-1	4
Interest	27	-0	12	23	22	11	16	7
Depreciation	32	33	34	42	42	43	42	43
Profit before tax	124	154	131	107	70	55	111	133
Tax %	35%	33%	34%	-50%	26%	28%	26%	26%
Net Profit	81	104	87	160	52	39	82	99
EPS in Rs	19.38	24.00	20.08	37.18	11.94	9.07	18.99	22.99
Raw PDF	—	—	—	—	—	—	—	—

EPIGRAL profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	611	829	1,551	2,188	1,929	2,550	2,527	2,626
Expenses	416	567	1,041	1,499	1,448	1,839	1,960	2,043
Operating Profit	194	261	510	689	481	711	567	583
OPM %	32%	32%	33%	31%	25%	28%	22%	22%
Other Income	2	2	4	8	6	15	15	11
Interest	11	29	44	66	73	53	72	56
Depreciation	44	74	86	109	124	133	168	170
Profit before tax	141	161	383	523	291	540	342	368
Tax %	21%	37%	34%	32%	33%	34%	3%	—
Net Profit	112	101	253	353	196	357	333	272
EPS in Rs	27.19	24.48	60.84	85.04	47.12	82.68	77.19	62.99
Dividend Payout %	0%	0%	0%	6%	11%	7%	6%	—

EPIGRAL balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	41	42	42	42	42	42	43	43
Reserves	241	331	432	684	1,028	1,213	1,860	2,178
Borrowings	601	737	753	993	879	964	593	572
Other Liabilities	162	164	223	405	484	576	655	712
Total Liabilities	1,044	1,273	1,449	2,124	2,432	2,794	3,151	3,505
Fixed Assets	295	440	1,102	1,068	1,804	1,767	2,238	2,117
CWIP	468	691	126	589	158	483	64	451
Investments	0	0	0	0	21	21	97	23
Other Assets	281	142	221	467	449	524	752	915
Total Assets	1,044	1,273	1,449	2,124	2,432	2,794	3,151	3,505

EPIGRAL cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	—	165	229	284	626	398	441	436
Cash from Investing Activity	—	-363	-197	-455	-437	-401	-262	-355
Cash from Financing Activity	—	69	-32	195	-200	-8	-164	-94
Net Cash Flow	—	-129	1	24	-11	-11	15	-14
Free Cash Flow	—	-205	32	-172	210	-1	254	50
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit	—	99%	99%	68%	106%	93%	78%	90%

EPIGRAL shareholding pattern (%)
Category	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Promoters	68.94%	68.95%	68.83%	68.83%	68.83%	68.83%	68.83%	68.83%
FIIs	3.01%	3.01%	3.06%	2.71%	2.36%	1.54%	1.03%	0.99%
DIIs	4.31%	4.66%	4.78%	4.93%	5.13%	4.90%	5.56%	4.89%
Government	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
Public	23.71%	23.34%	23.30%	23.52%	23.67%	24.71%	24.56%	25.27%
No. of Shareholders	81,697	80,878	79,951	78,605	77,562	77,583	76,305	76,384

EPIGRAL key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	40	46	52	60	28	34	33	60
Inventory Days	58	64	51	74	69	90	105	89
Days Payable	52	62	69	42	36	63	50	66
Cash Conversion Cycle	46	48	34	92	61	61	88	83
Working Capital Days	-27	-76	-92	-26	-41	-54	26	16
ROCE %	36%	15%	16%	29%	32%	17%	25%	15%

EPIGRALUpdated 16 Oct 2026, 11:58

Epigral Limited

EPIGRALUpdated 16 Oct 2026, 11:58

Market Cap

₹4,280Cr.

Current Price

₹992

High / Low

₹1,730/806

Stock P/E

15.7

ROE15.8%

ROCE15.3%

Book Value₹515

Face Value₹10.0

Dividend Yield0.51%

About

Epigral Limited, formerly known as Meghmani Finechem Ltd, incorporated in 2007, is a leading integrated manufacturer of chemicals.[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	455	18	360	2	31	48	33	32	7.62
Sep 2023	478	21	370	1	32	56	32	38	9.18
Dec 2023	472	20	349	2	31	74	34	49	11.87
Mar 2024	525	14	369	2	30	113	32	77	18.45
Jun 2024	651	14	475	2	33	131	34	86	20.7
Sep 2024	626	27	448	6	32	124	35	81	19.38
Dec 2024	645	0	463	4	33	154	33	104	24
Mar 2025	628	12	454	3	34	131	34	87	20.08
Jun 2025	607	23	443	8	42	107	-50	160	37.18
Sep 2025	587	22	455	2	42	70	26	52	11.94
Dec 2025	597	11	494	6	43	55	28	39	9.07
Mar 2026	736	16	568	-1	42	111	26	82	18.99
Jun 2026	705	7	526	4	43	133	26	99	22.99

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2016	394	19	245	2	44	88	23	67	9.49
Mar 2017	392	14	248	1	55	75	11	67	9.4
Mar 2018	598	9	346	8	55	195	20	155	21.97
Mar 2019	710	25	405	16	54	242	25	183	44.38
Mar 2020	611	11	416	2	44	141	21	112	27.19
Mar 2021	829	29	567	2	74	161	37	101	24.48
Mar 2022	1551	44	1041	4	86	383	34	253	60.84
Mar 2023	2188	66	1499	8	109	523	32	353	85.04
Mar 2024	1929	73	1448	6	124	291	33	196	47.12
Mar 2025	2550	53	1839	15	133	540	34	357	82.68
Mar 2026	2527	72	1960	15	168	342	3	333	77.19
TTM	2626	56	2043	11	170	368	—	272	62.99

Shareholding pattern

As of Sep 2026%

Holder	Share
Promoters	68.83%
FIIs	0.99%
DIIs	4.89%
Government	0.02%
Public	25.27%

Shareholding trend

Ownership over time%

Quarter	Promoters	FIIs	DIIs	Government	Public
Dec 2023	71.38%	1.17%	0.05%	0.02%	27.37%
Mar 2024	71.49%	1.36%	0.02%	0.02%	27.1%
Jun 2024	71.58%	1.46%	0.18%	0.02%	26.75%
Sep 2024	71.58%	2.1%	1.17%	0.02%	25.12%
Dec 2024	68.94%	3.01%	4.31%	0.02%	23.71%
Mar 2025	68.95%	3.01%	4.66%	0.02%	23.34%
Jun 2025	68.83%	3.06%	4.78%	0.02%	23.3%
Sep 2025	68.83%	2.71%	4.93%	0.02%	23.52%
Dec 2025	68.83%	2.36%	5.13%	0.02%	23.67%
Mar 2026	68.83%	1.54%	4.9%	0.02%	24.71%
Jun 2026	68.83%	1.03%	5.56%	0.02%	24.56%
Sep 2026	68.83%	0.99%	4.89%	0.02%	25.27%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2016	71	224	190	55	540	364	69	0	106	540
Mar 2017	71	291	123	42	527	398	3	29	98	527
Mar 2018	71	447	74	79	671	347	79	71	173	671
Mar 2019	41	241	601	162	1044	295	468	0	281	1044
Mar 2020	42	331	737	164	1273	440	691	0	142	1273
Mar 2021	42	432	753	223	1449	1102	126	0	221	1449
Mar 2022	42	684	993	405	2124	1068	589	0	467	2124
Mar 2023	42	1028	879	484	2432	1804	158	21	449	2432
Mar 2024	42	1213	964	576	2794	1767	483	21	524	2794
Mar 2025	43	1860	593	655	3151	2238	64	97	752	3151
Mar 2026	43	2178	572	712	3505	2117	451	23	915	3505

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2016	—	—	—	—
Mar 2017	—	—	—	—
Mar 2018	—	—	—	—
Mar 2019	—	—	—	—
Mar 2020	165	-363	69	-129
Mar 2021	229	-197	-32	1
Mar 2022	284	-455	195	24
Mar 2023	626	-437	-200	-11
Mar 2024	398	-401	-8	-11
Mar 2025	441	-262	-164	15
Mar 2026	436	-355	-94	-14

Key ratios

Historical financial ratios

Category	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	43	41	47	40	46	52	60	28	34	33	60
Inventory Days	75	59	45	58	64	51	74	69	90	105	89
Days Payable	31	37	51	52	62	69	42	36	63	50	66
Cash Conversion Cycle	86	63	42	46	48	34	92	61	61	88	83
Working Capital Days	43	40	19	-27	-76	-92	-26	-41	-54	26	16
ROCE %	—	18%	37%	36%	15%	16%	29%	32%	17%	25%	15%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of EPIGRAL LIMITED (EPIGRAL)?

The reported market capitalisation for EPIGRAL LIMITED (EPIGRAL) is ₹4,280Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of EPIGRAL?

The current price shown for EPIGRAL LIMITED (EPIGRAL) on Fincrux is ₹992 with a 52-week high/low of ₹1,730/806.

What is the P/E ratio of EPIGRAL LIMITED (EPIGRAL)?

The stock P/E for EPIGRAL LIMITED (EPIGRAL) is 15.7 on Fincrux, with ROE at 15.8% and ROCE at 15.3%.

What were EPIGRAL latest quarterly results?

For Jun 2026, EPIGRAL LIMITED (EPIGRAL) reported sales ₹705 Cr and net profit ₹99 Cr (figures in ₹ crore unless noted).

What are EPIGRAL annual sales and net profit?

For TTM, EPIGRAL LIMITED (EPIGRAL) shows sales of ₹2,626 Cr and net profit of ₹272 Cr on the Fincrux profit & loss statement.

Who owns EPIGRAL LIMITED (EPIGRAL)?

Latest shareholding for EPIGRAL LIMITED (EPIGRAL) on Fincrux: Promoters 68.83% (Sep 2026), FIIs 0.99% (Sep 2026), DIIs 4.89% (Sep 2026), Government 0.02% (Sep 2026), Public 25.27% (Sep 2026).

Where can I find EPIGRAL LIMITED (EPIGRAL) financials?

EPIGRAL LIMITED (EPIGRAL) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show EPIGRAL balance sheet and cash flow?

Yes. The EPIGRAL LIMITED (EPIGRAL) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 16 October 2026 at 11:58